BD Targets Hospital-Associated Infections With $230 Mil. Acquisition
This article was originally published in The Gray Sheet
Executive Summary
BD's acquisition of molecular diagnostic firm GeneOhm Sciences enters the medical technology company into the purportedly $500 mil.-plus healthcare-associated infections market
You may also be interested in...
Dispute Arises Over Hospital-Acquired Infection Tests
French diagnostic firm BioMérieux is attempting to renege on a licensing agreement with Becton Dickinson relating to methods for detecting one of the most common infections picked up in hospitals, according to BD
Dispute Arises Over Hospital-Acquired Infection Tests
French diagnostic firm BioMérieux is attempting to renege on a licensing agreement with Becton Dickinson relating to methods for detecting one of the most common infections picked up in hospitals, according to BD
3M Beams Into Clinical Diagnostics With Acolyte Biomedica Acquisition
3M entered the clinical diagnostics market Feb. 14 with its acquisition of U.K.-based Acolyte Biomedica and the BacLite system for detecting hospital-associated infectious diseases